Sen. Wyden Asks Califf for Details on Accelerated Approval Policy
February 05, 2022
February 05, 2022
WASHINGTON, Feb. 5 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on Feb. 4, 2022:
Senate Finance Committee Chair Ron Wyden, D-Ore., today asked Robert Califf, nominee to lead the Food and Drug Administration (FDA) for details on how he would implement and enforce accelerated approvals for prescription drugs if he is confirmed by the Senate.
"Some companies have taken advantage of the Accelerated Approval Pa . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today asked Robert Califf, nominee to lead the Food and Drug Administration (FDA) for details on how he would implement and enforce accelerated approvals for prescription drugs if he is confirmed by the Senate.
"Some companies have taken advantage of the Accelerated Approval Pa . . .